By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Progenra, Inc. 

271A Great Valley Parkway

Malvern  Pennsylvania  19355  U.S.A.
Phone: 610-644-6974 Fax: 610-644-4705



Company News
Progenra, Inc. Receives Second Immune Oncology Patent 5/11/2017 6:08:37 AM
Progenra, Inc. Release: Biotech Discovers Novel Immune Oncology Drug 1/17/2017 11:09:05 AM
Eminent Immuno-Oncologist, Dr. Wayne Hancock, Joins Progenra, Inc.’S Scientific Advisory Board 10/31/2014 9:25:07 AM
Progenra, Inc.'s Novel USP7 Inhibitors are Shown to Exert Multiple Anti-Tumor Effects 10/8/2012 10:09:45 AM
New Study Demonstrating Progenra, Inc.'s Novel Anti-Tumor Compound Overcome VELCADE® (bortezomib) Resistant Multiple Myeloma Cells 9/17/2012 9:34:11 AM
New Study Demonstrating the Selectivity of Progenra, Inc.'s Novel Anti-Tumor Compound 11/28/2011 10:09:26 AM
Progenra, Inc. and Tokyo Medical University Form Rheumatoid Arthritis Research Collaboration 10/24/2011 7:29:41 AM
Progenra, Inc. and Ono Pharmaceutical Company, Ltd. Enter into Research Collaboration 10/11/2011 11:13:01 AM
Progenra, Inc. Receives Approval of Novel Patent for Isopeptidase High Throughput Screening Platform 7/26/2010 12:34:45 PM
LifeSensors Inc. Launches their Ubiquitin Pathway Enzymes Assay Kits Licensed from Progenra, Inc. 7/10/2009 8:53:13 AM